
SISAQOL-IMI consortium launches final recommendations
6 Feb 2025

World Cancer Day 2025: EORTC’s commitment to older patients
4 Feb 2025

EORTC and Immunocore announce enrolment of first patient onto the only active Phase 3 adjuvant trial in uveal melanoma
11 Dec 2024

Minister F. Vandenbroucke visits EORTC Headquarters to strengthen collaborative efforts in clinical cancer research
21 Nov 2024

IMMUcan has completed patient enrolment
12 Nov 2024

EORTC SPRINT clinical cancer study receives support from Rising Tide Foundation to reduce the burden for patients
5 Nov 2024

Pink October at EORTC: Over 60 years of impactful breast cancer research
29 Oct 2024

Spotlight on ENA 2024 News
25 Oct 2024